eMolecules Acquires Specs Compound Handling B.V.

eMolecules Acquires Synple Chem AG

September 24, 2024

Biotechnology

eMolecules, a San Diego-based provider of a chemical compound search-and-fulfillment platform and a portfolio company of Avista Healthcare Partners, has acquired Synple Chem AG, an automated chemical synthesis systems and services provider headquartered near Zurich, Switzerland. The acquisition adds Synple's automation technology and a virtual compound library of more than 7 trillion tractable compounds to eMolecules' existing offering, expanding its capabilities as a one-stop shop for compound procurement, management and automation for drug discovery customers.

Avista Capital Partners Invests in eMolecules

March 25, 2021

Healthcare Services

Avista Capital Partners has signed a definitive agreement to invest in eMolecules, a San Diego–based e-procurement and marketplace platform for high-value chemicals and bioreagents used in drug discovery. Financial terms were not disclosed; Avista said the investment will support eMolecules' growth and expansion into additional biopharma and academic customers.

Balchem Corporation Acquires Chemogas NV

May 2, 2019

Industrial Services

Balchem Corporation has agreed to acquire Chemogas NV, a Belgium-based provider of packaged specialty gases (notably ethylene oxide) and related services, from majority shareholder Gilde Equity Management. The acquisition expands Balchem's global footprint in packaged ethylene oxide and creates a worldwide network of facilities to better serve medical device sterilization and other industrial customers.

Ampersand Capital Partners Acquires Specac Ltd.

March 13, 2024

Manufacturing

Ampersand Capital Partners, a Boston-based private equity firm focused on healthcare and life sciences, has acquired Specac Ltd., a UK-based designer and manufacturer of FTIR spectroscopy accessories and sample preparation solutions. The acquisition will support Specac's growth trajectory and leverage Ampersand's experience in life-sciences-oriented lab products and OEM channels.

3E Acquires ChemChain

January 11, 2024

Cloud & SaaS

3E has acquired ChemChain, a Luxembourg-headquartered provider of blockchain-based digital product passport technology, to expand its Supply Chain & Sustainability offering and enhance the 3E Exchange platform. The acquisition brings ChemChain's proprietary IP and technology into 3E's compliance and digital product passport capabilities to accelerate supply chain transparency and sustainability solutions.

OpenGate Capital Acquires Chemisphere Corp.

January 18, 2022

Manufacturing

OpenGate Capital, a Los Angeles-based private equity firm, has acquired Chemisphere Corp., a specialty solvent blender and chemical distributor headquartered in St. Louis, Missouri, from founder Bob Schwent. The deal complements OpenGate’s recent acquisition of Chemsolv and creates a larger chemical distribution platform spanning the Midwest to the Mid‑Atlantic, with plans for organic growth and future add-on acquisitions.